Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/07/2012EP1948155B1 Pharmaceutical compositions comprising droxidopa
03/07/2012EP1940519B1 Pharmaceutical composition comprising artesunate, sulfamethoxypyrazine and pyrimethamine for use in the treatment of malaria within one day
03/07/2012EP1919891B1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/07/2012EP1919466B1 Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative
03/07/2012EP1868613B1 Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine
03/07/2012EP1768966B1 Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners
03/07/2012EP1754702B1 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity
03/07/2012EP1727803B1 Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof
03/07/2012EP1694644B1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
03/07/2012EP1663994B1 Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
03/07/2012EP1653928B1 Spray drying processes for forming solid amorphous dispersions of drugs and polymers
03/07/2012EP1638525B1 Inhalable formulations for treating pulmonary hypertension and methods of using same
03/07/2012EP1585518B1 Peptide deformylase inhibitors
03/07/2012EP1583506B1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
03/07/2012EP1572641B1 Method for production of theR,R (or S,S) configuration of glycopyrronium stereoisomers
03/07/2012EP1556414B1 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing the same
03/07/2012EP1542667B1 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1446412B1 Novel lna compositions and uses thereof
03/07/2012EP1438377B1 Cholesterol lowering structured lipids with omega 3 pufa
03/07/2012EP1390036B1 Prostanoic acid derivatives as agents for lowering intraocular pressure
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/07/2012EP1289540B1 Oncomodulin for treating neurological disorders
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012EP1017353B1 Therapeutic process for inhibiting nf-kappa b
03/07/2012EP1009388B1 Sustained release drug delivery devices
03/07/2012EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
03/07/2012CN202154882U 一种含有纳米辅酶q10颗粒的胶囊 A capsule containing nano-particles of coenzyme q10
03/07/2012CN1977888B Medicinal composition of baicalin, ganoderma lucidum and salvia miltrorrhiza
03/07/2012CN1946388B Use of nitric oxide precursors in medicine preparation
03/07/2012CN1869057B Preparation method of trialcohol group ginseng saponine and bialcohol group ginseng saponine
03/07/2012CN1861056B Slow-releasing preparation containing gastrodin
03/07/2012CN1854125B Aryl-group-substituted acrylonitrile compound, its production and use
03/07/2012CN1835943B 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and uses thereof
03/07/2012CN1636069B Method of determining a chemotherapeutic regimen based on ERCCI expression
03/07/2012CN102369289A Method for increasing concentration of avenanthramides in oats
03/07/2012CN102369283A Rnai molecule for thymidylate synthase and use thereof
03/07/2012CN102369282A Nucleic acid complex and nucleic acid-delivering composition
03/07/2012CN102369208A 6"-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides
03/07/2012CN102369205A Fused ring compound and use thereof
03/07/2012CN102369204A 3-deazaneplanocin derivatives
03/07/2012CN102369202A Azaquinolinone derivatives and uses thereof
03/07/2012CN102369201A Bicyclic amide derivatives for the treatment of respiratory depression
03/07/2012CN102369200A Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
03/07/2012CN102369198A Triazole antifungal agents
03/07/2012CN102369197A 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as adp receptor antagonists
03/07/2012CN102369196A Azetidines as histamine h3 receptor antagonists
03/07/2012CN102369195A Autotaxin inhibitors
03/07/2012CN102369194A Novel pyrazolone-derivatives and their use as PD4 inhibitors
03/07/2012CN102369193A Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
03/07/2012CN102369192A Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/07/2012CN102369191A Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/07/2012CN102369190A Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
03/07/2012CN102369189A Fluoroquinolone carboxylic acid molecular crystals
03/07/2012CN102369188A Substituted nicotinamides as KCNQ2/3 modulators
03/07/2012CN102369187A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
03/07/2012CN102369186A Piperidine and piperazine derivatives as autotaxin inhibitors
03/07/2012CN102369185A Indole derivatives for treating neurodegenerative diseases
03/07/2012CN102369014A Method of modulating HSF-1
03/07/2012CN102369011A Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
03/07/2012CN102369010A Treatment regimen utilizing neratinib for breast cancer
03/07/2012CN102369009A Co-crystal of etravirine and nicotinamide
03/07/2012CN102369008A Liposome composition
03/07/2012CN102369007A Composition for oral administration
03/07/2012CN102369006A Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
03/07/2012CN102369005A Production method for ubiquinone powder for use in preparations and product thereof
03/07/2012CN102369004A Treatment of psoriasis
03/07/2012CN102369002A Capecitabine rapidly disintegrating tablets
03/07/2012CN102369001A Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
03/07/2012CN102369000A Pharmaceutical composition comprising one or more fumaric acid esters
03/07/2012CN102368999A Sustained release systems of ascorbic acid phosphate
03/07/2012CN102368998A Methods of reducing the proliferation and viability of microbial agents
03/07/2012CN102368913A Reduction of risk of obesity
03/07/2012CN102368912A Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
03/07/2012CN102368905A Lysosomotropic inhibitors of acid ceramidase
03/07/2012CN102368904A Fatty acid monoglyceride compositions
03/07/2012CN102367285A Pearsonothuria graeffei fucosylated chondroitin sulfate, extracting method thereof, and purpose thereof
03/07/2012CN102367257A Single-crystal crystal forms of clopidogrel hydrochloride and preparation method and application thereof
03/07/2012CN102367254A More stable doxofylline compound and pharmaceutical composite thereof
03/07/2012CN102367252A Tropisetron hydrochloride compound
03/07/2012CN102367251A More stable tropisetron compound and pharmaceutical composition thereof
03/07/2012CN102367249A More stable pantoprazole compound and its pharmaceutical composition
03/07/2012CN102367248A Sparfloxacin hemisulphate, its preparation method and application
03/07/2012CN102367243A Stable potassium sodium dehydroandroan drographolide succinate compound and pharmaceutical composition thereof
03/07/2012CN102367239A 2-aryl-2,3-dihydro-4H-1,3-benzothiazine-4-ketone derivative and application thereof
03/07/2012CN102367229A Ethylenediamine diaceturate compound and pharmaceutical composition thereof
03/07/2012CN102367227A Stable Levocarnitine compound and pharmaceutical composition thereof
03/07/2012CN102366627A Protein sensitizer of tumor chemotherapeutics
03/07/2012CN102366623A Preparation method of traditional Chinese medicine for treating qi deficiency-type bedsore
03/07/2012CN102366603A Medicine for treating rheumatism, rheumatoid arthritis, pain in neck, shoulder, waist and lower extremities and preparation method thereof
03/07/2012CN102366601A Traditional Chinese medicine preparation for treating apoplexia, facial paralysis and hemiplegia
03/07/2012CN102366591A Chinese herbal medicinal wine for treating rheumatoid and rhenmatoid arthritis and its preparation method
03/07/2012CN102366567A Pharmaceutical composition for treating condyloma acuminatum, and preparation and application method
03/07/2012CN102366544A Bedsore ointment and preparation method thereof
03/07/2012CN102366533A Pharmaceutical composition for treating hyperpyrexia and preparation method thereof
03/07/2012CN102366522A Chinese medicine pill for treating esophageal cancer and process technology
03/07/2012CN102366511A Method of preparing medicine for activating dormant cerebral nerves
03/07/2012CN102366505A Plaster for treating hypertension and preparation method thereof
03/07/2012CN102366497A Medicinal compound preparation for treating diabetes and preparation method of medicinal compound preparation
03/07/2012CN102366482A Chinese herbal medicine used for treating paddy-field dermatitis
1 ... 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 ... 7860